SEEL 519% upside according to this analyst

Von TopgOptions
SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.

On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to $4.00.

52 Week Range 0.76 - 6.60

Is this a strong buy? Looking forward to read your opinion about it.
buyFundamental AnalysisTechnical IndicatorsseelseelosseelostherapeuticssignalsignalprovidersignalservicesignalsprovidertherapeuticsTrend Analysis
TopgOptions

Haftungsausschluss